Posts classified under: General

News + Announcements

Investigational Drug Tinostamustine to be Included in GBM AGILE Clinical Trial for Glioblastoma

September 17, 2025 | BUSINESSWIRE

Global Coalition for Adaptive Research Announces Initiation of AZD1390 in GBM AGILE Trial

May 13, 2025 | PRNewswire

U.S. Department of Defense Taps Global Coalition for Adaptive Research to be the Regulatory Lead for PTSD Trial

February 6, 2025 | PRNewswire

GCAR Announces Evaluation of AZD1390 in GBM AGILE Trial

November 22, 2024 | PRNewswire

Oncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Anticipated Pancreatic Cancer Trial

May 15, 2024 | PRNewswire

PanCAN and GCAR Forge Alliance for Pancreatic Cancer Treatments

January 9, 2024 | PRNewswire

GCAR Joins South Pole Trek 4 Cancer to Raise Funds for Research

November 2, 2023 | BUSINESSWIRE

Children’s Tumor Foundation and Global Coalition for Adaptive Research Announce Strategic Alliance to Implement NF Platform Clinical Trial

October 5, 2023 | PRNewswire

Global Coalition for Adaptive Research’s Innovative Clinical Trial Platform Opens to Evaluate New Therapies for Brain Cancer

June 19, 2019 | BUSINESSWIRE

GCAR Appoints Jeffrey Tarrant to Board of Directors

June 13, 2019 | BUSINESSWIRE

FDA’s Woodcock Defends Accelerated Approvals and Talks of Culture Shift in Clinical Trials

June 5, 2019 | BIOPHARMA DIVE

Global Coalition for Adaptive Research (GCAR) Names Meredith Buxton Chief Operating Officer

January 31, 2019 | GLOBAL COALITION FOR ADAPTIVE RESEARCH

GCAR Names Gary Gordon as Interim Chief Executive Officer

November 8, 2018 | PRWEB

4 Ways Cancer is Changing How We Test Medicines

October 18, 2018 | POLITICO

Global Coalition for Adaptive Research Launches to Speed the Discovery & Development of Cures for Patients with Rare & Deadly Diseases

April 16, 2018 | BUSINESSWIRE

Could a New Business Model Make Clinical Drug Trials More Accessible to Patients?

March 8, 2018 | HARVARD BUSINESS SCHOOL